All In MedTech

FDA Clearance Tracker · P900023-S034

ABIOMED BVS 5000 BI-VENTRICULAR SUPPORT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 12, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 12, 2001

Approved

Time to decision

117 days

Received Nov 15, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P900023-S034
Device name
ABIOMED BVS 5000 BI-VENTRICULAR SUPPORT SYSTEM
Applicant location
Danvers, MA
Received
Nov 15, 2000
Decided
Mar 12, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P900023

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

APPROVAL TO REVISE THE LABELING TO INCLUDE CANNULATION OF THE LEFT VENTRICULAR APEX WITH ANY OF THE ATRIAL CANNULAE.

Source documents

Other decisions for Abiomed Cardiovascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.